Molecular classification, pathway addiction, andtherapeutic targeting in diffuse large B cell lymphoma

Soham Puvvada, Samantha Kendrick, Lisa Rimsza

Research output: Contribution to journalReview article

16 Scopus citations


The rapid emergence of molecularly based techniques to detect changes in the genetic landscape of diffuse large B cell lymphoma (DLBCL), including gene expression, DNA and RNA sequencing, and epigenetic profiling, has significantly influenced the understanding and therapeutic targeting of DLBCL. In this review, we briefly discuss the new methods used in the study of DLBCL. We describe the influence of the generated data on DLBCL classification and the identification of new entities and altered cell survival strategies, with a focus on the renewed interest in some classic oncogenic pathways that are currently targeted for new therapy. Finally, we examine the molecular genomic studies that revealed the importance of the tumor microenvironment in the pathogenesis of DLBCL.

Original languageEnglish (US)
Pages (from-to)257-265
Number of pages9
JournalCancer Genetics
Issue number7-8
StatePublished - Jul 1 2013



  • B cell receptor signaling
  • Diffuse large B cell lymphoma
  • Gene expression profiling
  • Oncogenes
  • Tumor microenvironment

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this